IMM-124E

BIOLOGICAL2 trials

Sponsors

Immuron Ltd., Miriam Vos, MD

Conditions

Non-alcoholic Steatohepatitis (NASH)Nonalcoholic Fatty Liver Disease (NAFLD)

Phase 2

A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis

CompletedNCT02316717

Immuron Ltd.Non-alcoholic Steatohepatitis (NASH)

Start: 2014-12-31End: 2017-10-30Updated: 2020-02-21

Anti-LPS Antibody Treatment for Pediatric NAFLD

CompletedNCT03042767

Miriam Vos, MDNonalcoholic Fatty Liver Disease (NAFLD)

Start: 2017-02-01End: 2019-10-23Updated: 2021-05-24

Related Papers

MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials

Radiology2022-11-017 citations